| Masroor Alam, MD | |
|
1 Medical Village Dr, Independent Anesthesiologists Psc, Edgewood, KY 41017-3403 | |
| (859) 341-7246 | |
| (859) 341-7867 |
| Full Name | Masroor Alam |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 35 Years |
| Location | 1 Medical Village Dr, Edgewood, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720069388 | NPI | - | NPPES |
| 0982843 | Medicaid | OH | |
| 200320150 | Medicaid | IN | |
| 611077369 | Other | TAX ID | |
| 64028475 | Medicaid | KY | |
| 311585770 1720069388 | Other | HEALTHNET | |
| 000000192691 | Other | ANTHEM BLUE SHIELD | |
| 000000642262 | Other | ANTHEM | |
| 11179782 | Other | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 36170 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dearborn County Hospital | Lawrenceburg, IN | Hospital |
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| St Elizabeth Florence | Florence, KY | Hospital |
| St Elizabeth Ft Thomas | Fort thomas, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Group Practice Inc | 1254245137 | 361 |
| Anesthesia Group Practice Inc | 1254245137 | 361 |
| Anesthesia Group Practice Inc | 1254245137 | 361 |
News Archive
Oncolytics Biotech Inc. today announced that SAFC, a Division of Sigma-Aldrich Corporation, has commenced validation activities designed to demonstrate the manufacturing process for the commercial production of REOLYSIN, Oncolytics' proprietary formulation of reovirus, is robust and reproducible.
One study suggested that 42 percent of people with type 2 diabetes who are treated for the disease do not reach their blood sugar goals, putting them at higher risk of organ and tissue damage, blindness and even death. We wanted to explore potential causes of clinical inertia among physicians and people with diabetes, which may lead to sub-optimal care.
Runners taking part in the April 2010 London Marathon can boost their recovery time by drinking tart cherry juice before and after the race, according to a researcher at Northumbria University.
Genentech, Inc. a wholly owned member of the Roche Group, and Biogen Idec announced today a Phase III study (STAGE) of the investigational humanized anti-CD20 monoclonal antibody ocrelizumab given in combination with methotrexate (MTX) met its primary endpoint of improving signs and symptoms (as measured by American College of Rheumatology or ACR20 response) in rheumatoid arthritis (RA) patients who had an inadequate response to MTX at both 24 and 48 weeks.
› Verified 6 days ago
| Entity Name | Anesthesia Group Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417951948 PECOS PAC ID: 1254245137 Enrollment ID: O20031114000492 |
News Archive
Oncolytics Biotech Inc. today announced that SAFC, a Division of Sigma-Aldrich Corporation, has commenced validation activities designed to demonstrate the manufacturing process for the commercial production of REOLYSIN, Oncolytics' proprietary formulation of reovirus, is robust and reproducible.
One study suggested that 42 percent of people with type 2 diabetes who are treated for the disease do not reach their blood sugar goals, putting them at higher risk of organ and tissue damage, blindness and even death. We wanted to explore potential causes of clinical inertia among physicians and people with diabetes, which may lead to sub-optimal care.
Runners taking part in the April 2010 London Marathon can boost their recovery time by drinking tart cherry juice before and after the race, according to a researcher at Northumbria University.
Genentech, Inc. a wholly owned member of the Roche Group, and Biogen Idec announced today a Phase III study (STAGE) of the investigational humanized anti-CD20 monoclonal antibody ocrelizumab given in combination with methotrexate (MTX) met its primary endpoint of improving signs and symptoms (as measured by American College of Rheumatology or ACR20 response) in rheumatoid arthritis (RA) patients who had an inadequate response to MTX at both 24 and 48 weeks.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Masroor Alam, MD 20 Medical Village Dr, Ste 258, Edgewood, KY 41017-5401 Ph: (859) 341-7246 | Masroor Alam, MD 1 Medical Village Dr, Independent Anesthesiologists Psc, Edgewood, KY 41017-3403 Ph: (859) 341-7246 |
News Archive
Oncolytics Biotech Inc. today announced that SAFC, a Division of Sigma-Aldrich Corporation, has commenced validation activities designed to demonstrate the manufacturing process for the commercial production of REOLYSIN, Oncolytics' proprietary formulation of reovirus, is robust and reproducible.
One study suggested that 42 percent of people with type 2 diabetes who are treated for the disease do not reach their blood sugar goals, putting them at higher risk of organ and tissue damage, blindness and even death. We wanted to explore potential causes of clinical inertia among physicians and people with diabetes, which may lead to sub-optimal care.
Runners taking part in the April 2010 London Marathon can boost their recovery time by drinking tart cherry juice before and after the race, according to a researcher at Northumbria University.
Genentech, Inc. a wholly owned member of the Roche Group, and Biogen Idec announced today a Phase III study (STAGE) of the investigational humanized anti-CD20 monoclonal antibody ocrelizumab given in combination with methotrexate (MTX) met its primary endpoint of improving signs and symptoms (as measured by American College of Rheumatology or ACR20 response) in rheumatoid arthritis (RA) patients who had an inadequate response to MTX at both 24 and 48 weeks.
› Verified 6 days ago
Raymond James Sullivan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 20 Medical Village Dr, Independent Anesthesiologists. Psc, Edgewood, KY 41017 Phone: 859-341-7246 Fax: 859-341-7867 | |
David Zangrando, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 849-341-7246 Fax: 859-341-7867 | |
Timothy Dale Dickinson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-341-7246 Fax: 859-341-7867 | |
Marian Jeanne Gorham, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Independent Anesthesiologists Psc, Edgewood, KY 41017 Phone: 859-341-7246 Fax: 859-341-7867 | |
Richard Gerard Oliver, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Independent Anesthesiologists Psc, Edgewood, KY 41017 Phone: 859-341-7246 Fax: 859-641-7867 | |
Steven Peter Noll, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Independent Anesthesiologists Psc, Edgewood, KY 41017 Phone: 859-341-7246 Fax: 859-341-7867 | |
Dr. Oren Costantini, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-2000 Fax: 859-341-7867 |